Focusing on oncogenic driver mutations and resistance mechan

Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.

Related Keywords

, Higher Education , Cancer , Fell , Lung Cancer , Non Small Cell Lung Cancer , Small Cell Lung Cancer , Biomarker , Drugs , Exon , Gene , Growth Factor , Distology , Hc , Immunohistochemistry , Immunotherapy , Inase , Migand , Lymphoma , Utation , Oncogene , Pd L1 , Eceptor , Research , Transfection , Tyrosine ,